These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3669751)

  • 41. Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells.
    Billard C; Sigaux F; Castaigne S; Valensi F; Flandrin G; Degos L; Falcoff E; Aguet M
    Blood; 1986 Mar; 67(3):821-6. PubMed ID: 2936410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphological and immunological changes of hairy cell leukemia during alpha-2-interferon therapy.
    Fridrik MA; Wahl G; Herbinger W; Schützenberger W; Gastl G; Huber C; Krönke M; Höpfel I
    Blut; 1989 May; 58(5):261-4. PubMed ID: 2720174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.
    Korsmeyer SJ; Greene WC; Cossman J; Hsu SM; Jensen JP; Neckers LM; Marshall SL; Bakhshi A; Depper JM; Leonard WJ; Jaffe ES; Waldmann TA
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4522-6. PubMed ID: 6192435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between immunological phenotype and hematological response to alpha-IFN treatment in 35 patients with hairy cell leukemia.
    Lauria F; Zinzani PL; Raspadori D; Foà R; Buzzi M; Gugliotta L; Bocchia M; Benfenati D; Tura S
    Eur J Haematol Suppl; 1990; 52():3-6. PubMed ID: 2279543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central nervous system involvement in hairy cell leukemia.
    Knecht H; Budmiger H; Groscurth P; Streuli RA
    Klin Wochenschr; 1985 May; 63(9):423-7. PubMed ID: 3999626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigating hairy cell leukemia dysregulations. Looking for interferon alpha site of action in hairy cells.
    Genot E; Wietzerbin J
    Leuk Lymphoma; 1994; 14 Suppl 1():23-6. PubMed ID: 7820049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro response of cells from three patients with hairy cell leukemia to a recombinant leukocyte interferon.
    Hiraoka A; Rosner MC; Golomb HM
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 49(1):73-82. PubMed ID: 2862737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone marrow morphology during alpha-interferon treatment in hairy cell leukemia.
    Hassan IB; Sundström C; Hagberg H
    Eur J Haematol; 1989 Aug; 43(2):120-6. PubMed ID: 2792319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of cultivation and interferon treatment on the surface morphology of hairy cell leukemia cells.
    Gamliel H; Hiraoka A; Golomb HM
    Cancer Invest; 1987; 5(5):389-99. PubMed ID: 3427505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of immune functions by long-term treatment with recombinant interferon-alpha 2 in a patient with hairy-cell leukemia.
    Teichmann JV; Sieber G; Ludwig WD; Ruehl H
    J Interferon Res; 1988 Feb; 8(1):15-24. PubMed ID: 3259251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Morphofunctional heterogeneity of leukemic cells in hairy cell leukemia].
    Lebedeva NB; Frenkel' MA
    Klin Lab Diagn; 1994; (3):3-5. PubMed ID: 7921813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A unique variant of hairy cell leukemia in Japan.
    Machii T; Tokumine Y; Inoue R; Kitani T
    Jpn J Med; 1990; 29(4):379-83. PubMed ID: 2273621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. alpha-IFN treatment does not induce Ki-ras expression in hairy-cell leukemia patients.
    Giron ML; Mercier G; Sigaux F; Castaigne S; Flandrin G; Degos L; Emanoïl-Ravier R
    Blut; 1989 Feb; 58(2):83-4. PubMed ID: 2645955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hairy cell leukemia: a tumor of pre-plasma cells.
    Anderson KC; Boyd AW; Fisher DC; Leslie D; Schlossman SF; Nadler LM
    Blood; 1985 Mar; 65(3):620-9. PubMed ID: 3871642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia.
    Lehn P; Sigaux F; Grausz D; Loiseau P; Castaigne S; Degos L; Flandrin G; Dautry F
    Blood; 1986 Oct; 68(4):967-70. PubMed ID: 3530350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotype of the hairy cells of leukemic reticuloendotheliosis defined by monoclonal antibodies.
    Janckila AJ; Stelzer GT; Wallace JH; Yam LT
    Am J Clin Pathol; 1983 Apr; 79(4):431-7. PubMed ID: 6340460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation.
    Harvey W; Srour EF; Turner R; Carey R; Maze R; Starrett B; Kanagala R; Pereira D; Merchant P; Taylor M
    Leuk Res; 1991; 15(8):733-44. PubMed ID: 1895754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of HLA Antigens, Interleukin 2 Receptor and B-Cell Growth Factor in Interferon Action in Hairy Cell Leukemia.
    Gamliel H; Gurfel D; Wu SH; Salzberg S; Golomb HM
    Leuk Lymphoma; 1990; 2(3-4):235-42. PubMed ID: 27456740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytochemical, cytogenetic, immunophenotypic and tumorigenic characterization of two hairy cell lines.
    Faguet GB; Satya-Prakash KL; Agee JF
    Blood; 1988 Feb; 71(2):422-9. PubMed ID: 2827813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon-alpha downregulates the abnormal intracytoplasmic free calcium concentration of tumor cells in hairy cell leukemia.
    Génot E; Bismuth G; Degos L; Sigaux F; Wietzerbin J
    Blood; 1992 Oct; 80(8):2060-5. PubMed ID: 1382718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.